Monday 20 January 2025
The official language of the this meeting is English. No translation and/or subtitles will be provided during the sessions.
| Time | Session |
| 13.30-14.00 | Registration and coffee |
| 14.00-14.30 | Welcome, introduction, and the Precision Psychiatry Roadmap Initiative Chair: Martien Kas, The Netherlands |
| 14.30-15.15 | Opening lecture: Bridging the gaps towards precision psychiatry: mechanistic biomarkers for early detection and intervention Speaker: Kim Q. Do, Switzerland |
| 15.15-15.45 | Discussion and Q&A |
| 15.45-16.15 | Break |
| 16.15-17.45 | Session 1: Biomarker development and validation Chair: Derek Buhl, United States |
| 16.15-16.45 | 1. Biomarker selection and alignment in a global prospective cohort study of clinical high risk for psychosis Speaker: Michael Sand, United States |
| 16.45-17.15 | 2. Stimulating future precision psychiatry biomarker development programmes Speaker: Rouba Kozak, United States |
| 17.15-17.45 | 3. Industry perspective and application of precision psychiatry biomarkers Speaker: Elizabeth Tunbridge, Germany |
| 17.45-18.45 | Discussion and conclusions day 1 |
| 18.45-19.15 | Drinks |
| 19.15-late | Networking dinner |
Tuesday 21 January 2025
| Time | Session |
| 08.30-12.00 | Session 2: Subtyping patient populations Chair: Peter Falkai, Germany |
| 08.30-09.00 | 1. Diagnostic formulations in precisions psychiatry Speaker: Maria Oquendo, United States |
| 09.00-09.30 | 2. Brain-derived measures for psychosis biotyping Speaker: Carol Tamminga, United States |
| 09.30-10.00 | 3. Neuro-imaging markers for precision psychiatry: depression as an example Speaker: Nikolaos Koutsouleris, Germany |
| 10.00-10.30 | Coffee break |
| 10.30-11.00 | 4. Multimodal biomarkers Speaker: Gitte Moos Knudsen, Denmark |
| 11.00-12.00 | Panel discussion with speakers and representative of the European Medical Agency: Ewa Bałkowiec-Iskra, Poland |
| 12.00-12.45 | Lunch |
| 12.45-15.00 | Session 3: Targeted interventions in stratified patient groups Chair: Andreas Reif, Germany |
| 12.45-13.15 | 1. Immuno-metabolic depression: strategies and treatment options Speaker: Brenda Penninx, Netherlands |
| 13.15-13.45 | 2. Patient stratification and psychotherapy Speaker: Frank J. Padberg, Germany |
| 13.45-14.15 | 3. The future of precision psychiatry: an industry perspective Speaker: Wayne C. Drevets, United States |
| 14.15-14.55 | Panel discussion with speakers and patient representative: Shaun Johnson, United Kingdom |
| 14.55-15.00 | Conclusions and closing words |